Drug information. Estramustini phophas (Estracyt)
Helsingborg/Lundbeck, L.
Ugeskrift for Laeger 137(38): 2203-2204
1975
ISSN/ISBN: 0041-5782 PMID: 1166562 Document Number: 82980
Document emailed within 1 workday
Related Documents
Pearson, R.E.; Schmalgemeier, W.; Bendall, M.; Mehta, P. 1972: Michigan regional drug information network. 3. Utilization of information received from a drug information center American Journal of Hospital Pharmacy 29(3): 229-234Yamanaka, H.; Shida, K. 1984: Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt" Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(3): 537-544
Mehlum, L.I.; Frost, S.K. 2004: Problem-oriented drug information: the RELIS database, a free drug information on the Internet for Scandinavian health professionals Ugeskrift for Laeger 166(34): 2886-2887
Sakji, S.; Letord, C.; Pereira, S.; Dahamna, B.; Joubert, M.; Darmoni, J. 2009: Drug information portal in Europe: information retrieval with multiple health terminologies Studies in Health Technology and Informatics 150: 497-501
Oakley, A. 2005: Focus on: information technology. Online drug information for dermatology patients Journal of drugs in dermatology: JDD 4(1): 108-113
Singhal, S.; Shah, R.B.; Piparva, K.G.; Dutta, S. 2023: Are we providing complete drug information to its users? Status of information adequacy of package insert in India Journal of Family Medicine and Primary Care 12(7): 1399-1405
Karlsson, Y. 1977: Central management of all drug information? Information of industries should be decreased strongly. There should be fewer consultants and they should be given a new role Nordisk Medicin 92(11): 284-285
Khodambashi, S.; Haugland, D.; Ellingsberg, A.; Kottum, H.; Sund, J.K.; Nytrø, Øy. 2017: An Experimental Comparison of a Co-Design Visualizing Personal Drug Information and Patient Information Leaflets: Usability Aspects Studies in Health Technology and Informatics 245: 748-752
Schwabe, U. 1980: The influence of the drug legislation on drug information for the physician and patient Der Internist 21(6): 311-317
Robinson, L.A. 1979: Pediatric drug information: drug therapy in nursing mothers Pediatric Nursing 5(6): 68-69; 84
Wojas, A.M.; Graham, A.S. 2009: Drug information services: the answer to your drug-related questions American Family Physician 80(7): 670
Greene, R.J. 1973: Drug administration. 2. Drug information at ward level Nursing Times 69(31): 992-993
Nilsson, T. 1980: Estracyt--clinical experiences Scandinavian Journal of Urology and Nephrology. Supplementum 55: 135-138
Nilsson, T. 1980: Clinical experience with Estracyt Acta Urologica Belgica 48(1): 133-137
Yamanaka, H.; Shimazaki, J.; Imai, K.; Sugiyama, Y.; Shida, K. 1977: Effect of estracyt on the rat prostate Investigative Urology 14(5): 400-404
Whitehouse, P.J.; Sciulli, C.G.; Mason, R.M. 1997: Dementia drug development: use of information systems to harmonize global drug development Psychopharmacology Bulletin 33(1): 129-133
Bouffioux, C.; de Leval, J. 1980: Estracyt, new therapeutic agent for cancer of the prostate Revue Medicale de Liege 35(24): 865-870
Bayanova, E.V. 1983: Recherche par l'information de brevets des objectifs de la technique dans un service d'information - Searching by patent information of the goals of technology in an information service Naucno-Tehniceskaa Informacia. Seria 1. Organizacia i Metodika Informacionnoj Raboty (8): 13-18
Bayanova, E.V. 1983: Recherche par l'information de brevets des objectifs de la technique dans un service d'information - Searching by patent information of the goals of technology in an information service Naucno-Tehniceskaa Informacia. Seria 1. Organizacia i Metodika Informacionnoj Raboty (8): 13-18
Jönsson, G. 1971: Continued experiences with Estracyt in the treatment of advanced prostatic cancer Nordisk Medicin 85(6): 186-187